Amalgamated Bank’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
Other funds holding AMPH
Amalgamated Bank's AMPH Position: Q3 2026 in Review
Amalgamated Bank opened a new position in Amphastar Pharmaceuticals (AMPH) in Q3 2026: 8,182 shares worth $211K. The stake represents ﹤0.01% of the portfolio and ranks #1560 among its holdings. This is a return to the name: Amalgamated Bank previously reported a position in AMPH as recently as Q1 2026.
Amalgamated Bank first reported a position in AMPH in Q2 2021 and has held it in 21 quarters since. The position peaked at $1.01M in Q4 2023. 35 funds tracked by Wall St. Rank hold AMPH as of Q3 2026.
- Amalgamated Bank held 8,182 shares of Amphastar Pharmaceuticals worth $211K as of Q3 2026.
- Amphastar Pharmaceuticals was a new Amalgamated Bank position in Q3 2026.
- Amphastar Pharmaceuticals made up ﹤0.01% of Amalgamated Bank's portfolio in Q3 2026, its #1560 holding.
- Amalgamated Bank first reported a position in Amphastar Pharmaceuticals in Q2 2021 and has held it in 21 quarters since.
- Amalgamated Bank's Amphastar Pharmaceuticals position peaked at $1.01M in Q4 2023.
- 35 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q3 2026.
Based on Amalgamated Bank's 13F filing for Q3 2026, filed 23 Oct 2026.